SCHEMBL9205145

SCHEMBL9205145

O=C(Cc1c[nH]c2ccccc12)Nc1ccccc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.62
MEN1 O00255 3/20 0.62
LMNA P02545 3/20 0.62
KDM4E B2RXH2 2/20 0.62
HPGD P15428 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
PTGER4 P35408 1/20 0.62
MAPK8 P45983 1/20 0.57
MAPT P10636 4/20 0.56
STAT3 P40763 1/20 0.56
RAB9A P51151 1/20 0.56
HSD17B10 Q99714 1/20 0.56
ALDH1A1 P00352 3/20 0.56
GLA P06280 1/20 0.55
SLC6A2 P23975 1/20 0.53
FNTA P49354 1/20 0.53
FNTB P49356 1/20 0.53
CYP1A2 P05177 1/20 0.53
POLB P06746 1/20 0.53
CYP3A4 P08684 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9202235 0.89 CFTR (0.57) KMT2AMEN1KDM4EHPGDSMN1; SMN2
SCHEMBL9208939 0.87 MAPT (0.62) KMT2AMEN1HPGDMAPTRAB9A
SCHEMBL28619019 0.87 MAPK8 (0.55) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL9205772 0.86 MAPK8 (0.65) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL5210851 0.86 MAPT (0.60) KMT2AMEN1LMNASMN1; SMN2MAPK8
SCHEMBL14441237 0.85 MAPT (0.69) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL28369557 0.84 MAPT (0.58) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL18229447 0.83 MAPT (0.57) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL18229452 0.83 CTSL (0.62) KMT2AMEN1LMNAKDM4EHPGD
SCHEMBL28373392 0.83 MAPT (0.59) KMT2AMEN1LMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113248399-A O-amino aromatic amide derivative and preparation method and application thereof 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2021-08-13 CN disclosed
EP-0475755-B1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof LILLY CO ELI (US) 1995-09-27 EP disclosed
US-5196427-A Gastrointestinal and central nervous system disorders; hormone inhibitors ELI LILLY AND COMPANY (US) 1993-03-23 US disclosed
EP-0475755-A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof ELI LILLY AND COMPANY (US) 1992-03-18 EP disclosed
US-5075313-A For bindign to cholecystokinin receptors ELI LILLY AND COMPANY (US) 1991-12-24 US disclosed